3D Printing in Healthcare Global Market Report 2024

The 3d printing in healthcare market size has grown rapidly in recent years. It will grow from $1.73 billion in 2023 to $2.08 billion in 2024 at a compound annual growth rate (CAGR) of 19.8%. The growth witnessed in the historical period can be attributed to progress in medical imaging, customization for patient care, regulatory approvals, adherence to standards, the rise in chronic diseases, and the increasing healthcare expenditure.

The 3d printing in healthcare market size is expected to see rapid growth in the next few years. It will grow to $4.24 billion in 2028 at a compound annual growth rate (CAGR) of 19.5%. The expansion anticipated in the forecast period can be credited to the emergence of bioprinting, telehealth, and remote medicine, the increasing aging population, government initiatives and funding, as well as patient education and engagement. Significant trends in the forecast period encompass advancements in bioprinting, personalized implant manufacturing, the integration of artificial intelligence (AI), the development of 3D-printed pharmaceuticals, and applications in dental prosthetics and orthodontics.

The anticipated increase in government funding for 3D printing is poised to drive the growth of the 3D printing market in healthcare. Government initiatives encompass specific actions, programs, or policies implemented by governments at different levels to address issues, achieve goals, and promote the well-being and overall development of the country. The infusion of government funds into 3D printing revolutionizes traditional design processes, facilitating the development of new approaches to optimize individual patient therapy. For example, in April 2022, the University Hospital Hamburg-Eppendorf (UKE) secured €2 million ($2.13 million) from the European Union's REACT-EU program for two investigative research projects. These projects, focusing on the use of 3D printing and artificial intelligence for medication and implant creation, showcase the impact of increasing government funding on driving advancements in 3D printing within the healthcare sector.

The escalating prevalence of chronic diseases is expected to propel the growth of the 3D printing market. Chronic diseases, characterized by persistent and often incurable medical conditions such as diabetes, hypertension, and arthritis, necessitate personalized and precise solutions. 3D printing plays a crucial role in creating customized medical devices and implants, enhancing treatment options for chronic diseases. For instance, in January 2023, the National Institutes of Health (NIH) projected a substantial increase in the occurrence of chronic illnesses in the US working-age demographic, with a 99.5% surge in individuals aged 50 and above with at least one chronic disease between 2020 and 2035. Thus, the rising incidence of chronic diseases serves as a driving force for the 3D printing market.

The challenge of a shortage of skilled labor is anticipated to impede the progress of 3D printing in the healthcare market. In healthcare 3D printing, complex processes require expertise in areas such as computer-aided design (CAD), 3D printing software, material science, and biotechnology. Skilled professionals are crucial for the effective operation, maintenance, and troubleshooting of 3D printers and related equipment. For example, in October 2022, Toner Buzz reported that up to 71% of companies believed a lack of skills or training was hindering the effective utilization of 3D printing technology. Consequently, the shortage of skilled labor stands as a restraint for 3D printing in the healthcare market.

Major companies in the 3D printing healthcare sector are intensifying their focus on developing next-generation products with advanced technologies to gain a competitive edge. Dental 3D printers, leveraging digital light processing (DLP) technology, combine advanced resin science with 3D printing to deliver superior strength, aesthetics, and durability. For instance, in February 2022, Desktop Health launched Einstein, the most precise dental 3D printer, and Flexcera Smile Ultra+ Resin, a dental resin for 3D printed dental restorations utilizing DLP technology. This combination enables dental professionals to provide accurate, customized smiles for both permanent and temporary dental restorations across various applications. The advanced Flexcera Smile Ultra+ has received FDA 510(k) clearance as a Class 2 medical device, designed for enduring, printable dental restorations.

In October 2021, 3D Systems acquired Volumetric Biotechnologies for an undisclosed amount, signaling a strategic move to establish a premier research facility in Houston, Texas. This facility is dedicated to pioneering advancements in life sciences-related technologies. Volumetric Biotechnologies, a biotechnology company specializing in 3D printing in healthcare, became part of 3D Systems, further strengthening the company's position in the evolving landscape of healthcare-related 3D printing.

Major companies operating in the 3d printing in healthcare market report are General Electric Company, Hewlett-Packard Company, Stratasys Ltd., EOS GmbH - Electro Optical Systems, 3D Systems Corporation, Proto Labs Inc., Formlabs Inc., Materialise NV, Ultimaker BV, SLM Solutions Group AG, Arcam AB, The ExOne Company, EnvisionTEC GmbH, Concept Laser GmbH, MedPrin Regenerative Medical Technologies Co. Ltd., Medical Molding Inc., Nanoscribe GmbH & Co. KG, Oxford Performance Materials Inc., Aspect Biosystems Ltd., FlashForge Corporation, Cyfuse Biomedical K.K., Mcor Technologies Ltd., Anatomics Pty. Ltd., Organovo Holdings Inc, 3D Bioprinting Solutions, Allevi Inc.

North America was the largest region in the 3D printing in healthcare market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 3d printing in healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the 3D printing in the healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain, Canada, Italy, Spain.

The application of 3D printing in the healthcare sector entails producing a three-dimensional object by layering materials according to a digital design customized for healthcare purposes. This involves utilizing 3D design and printing technologies to create medical devices tailored to individual patients, anatomical models, and surgical tools.

The primary components of 3D printing in healthcare encompass systems, materials, and services. The provision of 3D printing services facilitates specialists in generating reference models through the utilization of MRI scans and CT scans, assisting surgeons in their preparations for surgeries. A range of technologies, including laser beam melting (LBM), electron beam melting (EBM), photopolymerization, droplet deposition, laminated object manufacturing, wax deposition modeling, and bio printing, contribute to this field. These technologies find diverse applications, such as creating personalized medical equipment, developing models for surgical planning and education, producing prosthetics and implants, advancing biomaterials, and printing personalized medicine. Moreover, these technologies are employed by various end users, including medical and surgical centers, pharmaceutical and biotechnology companies, and academic institutions.

The 3D printing in healthcare market research report is one of a series of new reports that provides 3D printing in healthcare market statistics, including 3D printing in healthcare industry global market size, regional shares, competitors with a 3D printing in healthcare market share, detailed 3D printing in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printing in healthcare industry. This 3D printing in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D printing in the healthcare market consists of revenues earned by entities by providing tailored medical solutions, and surgical training. The market value includes the value of related goods sold by the service provider or included within the service offering. The 3D printing in the healthcare market also includes sales of patient-specific prosthetics and orthopedic implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.